About
OSANG LLC, operating as OSANG Healthcare, is a South Korean leader in the development and manufacturing of advanced in-vitro diagnostic (IVD) medical devices and healthcare solutions. Founded in 1996, the company has expanded its focus from blood glucose measurement biosensors to a diverse portfolio that includes biochemical, immunological, and molecular diagnostics, as well as health functional foods aimed at chronic disease prevention. The company emphasizes point-of-care and rapid testing solutions, integrating blood-based diagnostic sensors, medical devices, and digital healthcare platforms. OSANG is known for its diagnostic biosensors for blood glucose, HbA1c, and cholesterol, with its flagship product, the OKRA Pro, allowing users to monitor blood sugar levels via a dedicated app. Additionally, OSANG offers devices for biochemical and immunological diagnosis, as well as molecular diagnostics for rapid infection identification, including COVID-19 testing kits. With a global presence, OSANG Healthcare has subsidiaries in the U.S. and Brazil and has formed strategic partnerships. The company is publicly listed on KOSDAQ and is recognized for its innovation in healthcare, aiming to improve health outcomes through advanced medical devices and digital health services.
Technologies
Keywords
Company Information
-
Employees 39
-
Founded 1996
Location
625 Fair Oaks Ave, South Pasadena, California, United States, 91030-2600
